Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 8, 2005, Pages 3325-3333

  Bogdanovich, Tatiana ^a   Esel, Duygu ^a   Kelly, Linda M ^a   Bozdogan, Bülent ^a   Credito, Kim ^a   Lin, Gengrong ^a   Smith, Kathy ^a   Ednie, Lois M ^a   Hoellman, Dianne B ^a   Appelbaum, Peter C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; DX 619; GATIFLOXACIN; LEVOFLOXACIN; LINEZOLID; METICILLIN; MOXIFLOXACIN; ORITAVANCIN; QUINOLONE DERIVATIVE; RANBEZOLID; SITAFLOXACIN; TEICOPLANIN; TIGECYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG ACTIVITY; DRUG POTENCY; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANTI-INFECTIVE AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 23044515457     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.8.3325-3333.2005     Document Type: Article

References (29)

1. Bannerman, T. L., G. A. Hancock, F. C. Tenover, and J. M. Miller. 1995. Pulsed-field electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus. J. Clin. Microbiol. 33:551-555.
2. Blumberg, H. M., D. Rimland, D. J. Carroll, P. Terry, and I. K. Wachsmuth. 1991. Rapid development of ciprofloxacin resistance in methicillin-susceptible and resistant Staphylococcus aureus. J. Infect. Dis. 163:1279-1285.
3. Bozdogan, B., D. Esel, C. Whitener, F. A. Browne, and P. C. Appelbaum. 2003. Antibacterial susceptibility of a vancomycin-resistant Staphylococcus aureus strain isolated at the Hershey Medical Center. J. Antimicrob. Chemother. 52:864-868.
4. Cercenado, E., F. Garcia-Garrote, and E. Bouza. 2001. In-vitro activity of linezolid against multiply resistant Gram-positive clinical isolates. J. Antimicrob. Chemother. 47:77-81.
5. Cuny, C., and W. Witte. 2000. In vitro activity of linezolid against staphylococci. Clin. Microbiol. Infect. 6:328-333.
6. Diekema, D. J., and R. N. Jones. 2000. Oxazolidinones. A review. Drugs 59:7-16.
7. Discotto L. F., L. E. Lawrence, K. L. Denbleyker, and J. F. Barrett. 2001. Staphylococcus aureus mutants selected by BMS-284756. Antimicrob. Agents Chemother. 45:3273-3275.
8. Henwood, C. J., D. M. Livermore, A. P. Johnson, D. James, M. Warner, A. Gardiner, and the Linezolid Study Group. 2000. Susceptibility of Gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid. J. Antimicrob. Chemother. 46:931-940.
9. Hershow, R. C., W. F. Khayr, and P. C. Schreckenberger. 1998. Ciprofloxacin resistance in methicillin-resistant Staphylococcus aureus: associated factors and resistance to other antibiotics. Antimicrob. Agents Chemother. 5:213-220.
10. Hiramatsu, K. 1998. The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan. Am. J. Med. 104:7S-10S.
11. Hoellman, D., G. Lin, L. M. Ednie, A. Rattan, M. R. Jacobs, and P. C. Appelbaum. 2003. Antipneumococcal and antistaphylococcal activities of ranbezolid (RBX 7644), a new oxazolidinone, compared to those of other agents. Antimicrob. Agents Chemother. 47:1148-1150.
12. Hooper, D. C., and J. S. Wolfson. 1991. Mode of action of the new quinolones: new data. Eur. J. Clin. Microbiol. Infect. Dis. 10:223-231.
13. Horii, T., Y. Suzuki, A. Monji, M. Morita, H. Muramatsu, Y. Kondo, M. Doi, A. Takeshita, T. Kanno, and M. Maekawa. 2003. Detection of mutations in quinolone resistance-determining regions in levofloxacin- and methicillin-resistant Staphylococcus aureus: effects of the mutations on fluoroquinolone MICs. Diagn. Microbiol. Infect. Dis. 46:139-145.
14. Kacica, M., and L. C. McDonald. 2004. Vancomycin-resistant Staphylococcus aureus-New York. Morb. Mortal. Wkly. Rep. 53:322-323.
15. Linde H. J., M. Schmidt, E. Fuchs, U. Reischl, H. H. Niller, and N. Lehn. 2001. In vitro activities of six quinolones and mechanisms of resistance in Staphylococcus aureus and coagulase-negative staphylococci. Antimicrob. Agents Chemother. 45:1553-1557.
16. Livermore, D. M. 2000. Quinupristin/dalfopristin and linezolid: where, when, which and whether to use? J. Antimicrob. Chemother. 46:347-350.
17. McDougal, L. K., C. D. Steward, G. E. Killgore, J. M. Chaitram, S. K. McAllister, and F. C. Tenover. 2003. Pulsed-field electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J. Clin. Microbiol. 41:5113-5120.
18. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically-sixth edition: approved standard. NCCLS publication no. M7-A6. National Committee for Clinical Laboratory Standards, Wayne, Pa.
19. Nichols, R. L. 1999. Optimal treatment of complicated skin and soft tissue infections. J. Antimicrob. Chemother. 44:19-23.
20. Oliveira, D. C., and H. de Lencastre. 2002. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 46: 2155-2161.
21. Pankuch, G. A., M. R. Jacobs, and P. C. Appelbaum. 1994. Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin and vancomycin by using time-kill methodology. Antimicrob. Agents Chemother. 38:2065-2072.
22. Piddock, L. J. 1998. Mechanisms of fluoroquinolones resistance: an update 1994-1998. Drugs 58(Suppl. 2):11-18.
23. Schmitz, F.-J., A. Fluit, S. Brisse, J. Verhoef, K. Koher, and D. Milatovic. 1999. Molecular epidemiology of quinolone resistance and comparative in vitro activities of new quinolones against European Staphylococcus aureus isolates. FEMS Immunol. Med. Microbiol. 26:281-287.
24. Schmitz, F. J., A. C. Fluit, D. Hafner, A. Beeck, M. Perdikouli, M. Boos, S. Scheuring, J. Verhoef, K. Kohrer, and C. von Eiff. 2000. Development of resistance to ciprofloxacin, rifampin and mupirocin in methicillin-susceptible and -resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 44: 3229-3231.
25. Sierra, J. M., F. Marco, J. Ruiz, M. T. Jimenez de Anta, and J. Vila. 2002. Correlation between the activity of different fluoroquinolones and the presence of mechanisms of quinolone resistance in epidemiologically related and unrelated strains of methicillin-susceptible and -resistant Staphylococcus aureus. Clin. Microbiol. Infect. 8:781-790.
26. Stevens, D. L., L. G. Smith, J. B. Bruss, M. A. McConnell-Martin, S. E. Duvall, W. M. Todd, and B. Hafkin. 2000. Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections. Antimicrob. Agents Chemother. 44:3408-3413.
27. Sutcliffe J., T. Grebe, A. Tail-Kamradt, and L. Wondrack. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:2562-2566.
28. Tenover, F. C., L. M. Weigel, P. C. Appelbaum, L. K. McDougal, J. Chailram, S. McAllister, N. Clark, G. Killgore, C. M. O'Hara, L. Jevill, J. B. Patel, and B. Bozdogan. 2004. Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob. Agents Chemother. 48:275-280.
29. Voss, A., D. Milatovic, C. Wallrauch-Schwarz, V. T. Rosdahl, and I. Braveny. 1994. Methicillin-resistant Staphylococcus aureus in Europe. Eur. J. Clin. Microbiol. Infect. Dis. 13:50-55.